New Molecule May Lead to Anti-Heart Attack Drug

Filed in archive Cardiovascular Health , Studies , Treatment on April 21, 2008

What happens before a heart attack (myocardial infarction)?


© gandhiji40



Dangerous clots of too many blood platelets will block the vessels, thereby causing a heart attack.

Research findings from Rockefeller University suggests that it is possible to dissolve the clots by a way of a clot-busting pill that attacks a receptor on the blood cells' surface.

When such kind of a pill happen, high risk patients can take it at the first sign of chest pains. A pill that patients can keep with them instead of the current treatments that physicians administer. That's means you gotta be rushed to the nearest hospital!

A new molecule called RUC-1 could be the key to such a pill, according to Rockefeller scientists:

Barry Coller, David Rockefeller Professor and head of the Allen and Frances Adler Laboratory of Blood and Vascular Biology, and laboratory manager Robert Blue have found a new molecule, called RUC-1, that not only appears to SideStep these problems but, unlike existing drugs, could be taken orally.

"RUC-1 could provide advantages over the currently available inhibitors," Blue says. If someone was at very high risk for having a heart attack, he could keep the drug on hand and take it the same way doctors currently suggest using aspirin, swallowing the pill at the first sign of chest pain. "This would be the same idea, only much more potent," he says.

Really great once this happens. Especially if truly without the side effects of current treatment. Let's wait and see.

Find more details from Rockefeller University.